Tafinlar
| Tafinlar | |
|---|---|
| Term | Tafinlar |
| Short definition | Tafinlar - (pronounced) (TA-fin-lar) drug used alone or with trametinib to treat certain types of anaplastic thyroid cancer, non-small cell lung cancer, melanoma, and other solid tumors that have a specific mutation (change) in the BRAF gene. It is also being studied in the treatment of other types of cancer. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Tafinlar - (pronounced) (TA-fin-lar) drug used alone or with trametinib to treat certain types of anaplastic thyroid cancer, non-small cell lung cancer, melanoma, and other solid tumors that have a specific mutation (change) in the BRAF gene. It is also being studied in the treatment of other types of cancer. Tafinlar blocks certain proteins made by the mutated BRAF gene, which may help prevent cancer cells from growing. It's a kind of kinase inhibitor. Also called dabrafenib mesylate
External links
- Medical encyclopedia article on Tafinlar
- Wikipedia's article - Tafinlar
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski